| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyperphosphatemia in chronic kidney disease patients, and UNI 494, which is being developed to treat acute kidney injury. Founded in 2016, the firm is headquartered in Los Altos, California.
Over the last 12 months, insiders at Unicycive Therapeutics, Inc. have bought $0 and sold $0 worth of Unicycive Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Unicycive Therapeutics, Inc. have bought $12,375 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 15,000 shares for transaction amount of $12,375 was made by Schiller Brigitte () on 2022‑05‑16.
| Increased Positions | 16 | +55.17% | 2M | +32.39% |
| Decreased Positions | 8 | -27.59% | 121,436 | -1.94% |
| New Positions | 8 | New | 1M | New |
| Sold Out Positions | 2 | Sold Out | 45,307 | Sold Out |
| Total Postitions | 37 | +27.59% | 8M | +30.45% |
| Vivo Capital, Llc | $10,382.00 | 8.52% | 1.79M | +652,901 | +57.42% | 2025-09-30 |
| Octagon Capital Advisors Lp | $5,800.00 | 4.76% | 1M | 0 | 0% | 2025-09-30 |
| Nantahala Capital Management, Llc | $5,447.00 | 4.47% | 939,202 | 0 | 0% | 2025-09-30 |
| Great Point Partners I Lp | $4,620.00 | 3.79% | 796,558 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $3,821.00 | 3.14% | 658,878 | +52,925 | +8.73% | 2025-09-30 |
| Logos Global Management Lp | $2,747.00 | 2.26% | 473,563 | +<1 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $729.00 | 0.6% | 125,727 | +66,941 | +113.87% | 2025-09-30 |
| Squarepoint Ops Llc | $680.00 | 0.56% | 117,327 | +117,327 | New | 2025-09-30 |
| Acuta Capital Partners, Llc | $348.00 | 0.29% | 59,985 | -2,914 | -4.63% | 2025-09-30 |
| State Street Corp | $318.00 | 0.26% | 54,827 | +42,304 | +337.81% | 2025-09-30 |